|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
SundayTeva's multiple sclerosis treatment shows some promise in study.
Teva’s multiple sclerosis treatment shows some promise in study
The Kansas City Star Copaxone, a multiple sclerosis treatment marketed by Kansas City-based Teva Neuroscience Inc., slowed the progress of the disease in a recent study.....<MORE> See all stories on this topic:<CLICK HERE> |